50 likes | 178 Views
BRIDG update HL7 Working Group Meeting San Diego January 2007. Douglas B. Fridsma Julie Evans Smita Hastak/Becky Angeles. BRIDG Advisory Board.
E N D
BRIDG updateHL7 Working Group MeetingSan Diego January 2007 Douglas B. Fridsma Julie Evans Smita Hastak/Becky Angeles
BRIDG Advisory Board • The mission of the BRIDG Advisory Board is to ensure that the furtherdevelopment, maintenance and governance of the model continue in acollaborative, open and coordinated manner. The Board will also manage the scope of the model and ensure that it is maintained. • BRIDG Stakeholders: HL7, FDA, NCI, CDISC • Members: • Doug Fridsma – co-leader (CDISC /NCI / U of Pittsburgh) • Julie Evans – co-leader (CDISC) • Becky Kush (CDISC) • Wayne Kubick (CDISC / Lincoln Technologies) • Landen Bain (CDISC / HL7) • Randy Levin (FDA) • Christo Andonyadis (NCI) • Charlie Mead (HL7 / NCI / BoozAllenHamilton) • Peter Covitz (NCI) • Chris Chute (HL7, Mayo Clinic) • Ed Tripp (HL7 / Abbott)
BRIDG Technical Harmonization Committee • The mission of the BRIDG Technical Harmonization Committee is to integrate BRIDG subprojects into the harmonized BRIDG model. • Members: • Doug Fridsma • Julie Evans • Smita Hastak • Advisor: • Charlie Mead
BRIDG modeling and harmonization activities • October • caBIG Labhub model • CDISC lab model • November • caBIG Patient study calendar • Portions of CDISC trial Design • December • CDISC SDTM (partial) • January • AE development of harmonizable artifact • February • Tentatively Trial Design Model, but may be C3PR or RPS/SPL • March and following • TBA